LUAD:

Qianyun Shen1, Yijie Yang1, Maoying Guan1

  • 1Department of Oncology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Discover oncology
|May 21, 2025
PubMed
概括

基于蛋白质氨酸甲基转移酶 (PRMTs) 的新预后模型可以预测肺腺癌 (LUAD) 患者的结果和免疫治疗反应. 该模型有助于制定针对LUAD的个性化治疗策略.